• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血栓栓塞症-急性肺栓塞病理生理学的前沿研究

Advanced Research in the Pathophysiology of Venous Thromboembolism-Acute Pulmonary Embolism.

作者信息

Imiela Anna M, Kucharska Joanna, Kukliński Franciszek, Fernandez Moreno Teresa, Dzik Konrad, Pruszczyk Piotr

机构信息

Department of Internal Diseases and Cardiology, Infant Jesus Clinical Hospital, Medical University of Warsaw, Lindleya 4 Street, 02-005 Warsaw, Poland.

Department of Intensive Cardiac Care, Medical University of Bialystok, 15-089 Białystok, Poland.

出版信息

Biomedicines. 2025 Apr 8;13(4):906. doi: 10.3390/biomedicines13040906.

DOI:10.3390/biomedicines13040906
PMID:40299499
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12025274/
Abstract

According to the literature, cardiovascular diseases (CVDs)-including myocardial infarction, stroke, and venous thromboembolism (VTE)-are among the leading causes of mortality and morbidity worldwide. Evidence suggests that CVDs share common risk factors and pathophysiological mechanisms. Similar to the Mosaic Theory of Hypertension proposed by Irvine Page in 1949, the pathophysiology of VTE is multifactorial, involving multiple interacting processes. The concept of immunothrombosis, introduced by Engelmann and Massberg in 2009, describes the interplay between the immune system and thrombosis. Both thrombosis and hemostasis share core mechanisms, including platelet activation and fibrin formation. Additionally, immune mediators-such as monocytes, neutrophil extracellular traps (NETs), lymphocytes, selectins, and various molecular factors-play a critical role in thrombus formation. This review highlights inflammation as a key risk factor for pulmonary embolism (APE). Immunity is central to the complex interactions among the coagulation cascade, platelets, endothelium, reactive oxygen species (ROS), and genetic factors. Specifically, we examine the roles of the endothelium, immune cells, and microRNAs (miRNAs) in the pathophysiology of APE and explore potential therapeutic targets. This review aims to elucidate the roles of the endothelium, immune cells, and miRNAs in the pathophysiology of APE and explore potential future perspective.

摘要

根据文献记载,心血管疾病(CVDs)——包括心肌梗死、中风和静脉血栓栓塞(VTE)——是全球范围内导致死亡和发病的主要原因之一。有证据表明,心血管疾病具有共同的风险因素和病理生理机制。与1949年欧文·佩奇提出的高血压镶嵌理论类似,静脉血栓栓塞的病理生理学是多因素的,涉及多个相互作用的过程。2009年恩格尔曼和马斯伯格提出的免疫血栓形成概念描述了免疫系统与血栓形成之间的相互作用。血栓形成和止血都有核心机制,包括血小板活化和纤维蛋白形成。此外,免疫介质——如单核细胞、中性粒细胞胞外陷阱(NETs)、淋巴细胞、选择素和各种分子因子——在血栓形成中起关键作用。本综述强调炎症是肺栓塞(APE)的关键风险因素。免疫在凝血级联、血小板、内皮、活性氧(ROS)和遗传因素之间的复杂相互作用中起着核心作用。具体而言,我们研究内皮、免疫细胞和微小RNA(miRNAs)在肺栓塞病理生理学中的作用,并探索潜在的治疗靶点。本综述旨在阐明内皮、免疫细胞和miRNAs在肺栓塞病理生理学中的作用,并探索潜在的未来前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/995d/12025274/0123343f4fcc/biomedicines-13-00906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/995d/12025274/5cdf742a12b3/biomedicines-13-00906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/995d/12025274/0123343f4fcc/biomedicines-13-00906-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/995d/12025274/5cdf742a12b3/biomedicines-13-00906-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/995d/12025274/0123343f4fcc/biomedicines-13-00906-g002.jpg

相似文献

1
Advanced Research in the Pathophysiology of Venous Thromboembolism-Acute Pulmonary Embolism.静脉血栓栓塞症-急性肺栓塞病理生理学的前沿研究
Biomedicines. 2025 Apr 8;13(4):906. doi: 10.3390/biomedicines13040906.
2
Acute Pulmonary Embolism and Immunity in Animal Models.急性肺栓塞与动物模型中的免疫
Arch Immunol Ther Exp (Warsz). 2024 Jan 24;72(1). doi: 10.2478/aite-2024-0003. eCollection 2024 Jan 1.
3
Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians.静脉血栓栓塞症:临床医师关注的血栓、炎症与免疫血栓形成
J Thromb Thrombolysis. 2017 Oct;44(3):377-385. doi: 10.1007/s11239-017-1528-7.
4
Recent Advances on the Molecular Mechanism and Clinical Trials of Venous Thromboembolism.静脉血栓栓塞症分子机制与临床试验的最新进展
J Inflamm Res. 2023 Dec 14;16:6167-6178. doi: 10.2147/JIR.S439205. eCollection 2023.
5
Immunothrombosis and thromboinflammation in host defense and disease.宿主防御和疾病中的免疫血栓形成和血栓炎症。
Platelets. 2021 Apr 3;32(3):314-324. doi: 10.1080/09537104.2020.1817360. Epub 2020 Sep 8.
6
Immunothrombosis and the Role of Platelets in Venous Thromboembolic Diseases.免疫血栓形成与血小板在静脉血栓栓塞性疾病中的作用。
Int J Mol Sci. 2022 Oct 29;23(21):13176. doi: 10.3390/ijms232113176.
7
Inflammation, Infection and Venous Thromboembolism.炎症、感染与静脉血栓栓塞症。
Circ Res. 2021 Jun 11;128(12):2017-2036. doi: 10.1161/CIRCRESAHA.121.318225. Epub 2021 Jun 10.
8
COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms.COVID-19、免疫血栓形成和静脉血栓栓塞症:生物学机制。
Thorax. 2021 Apr;76(4):412-420. doi: 10.1136/thoraxjnl-2020-216243. Epub 2021 Jan 6.
9
Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond.血小板是多功能细胞:在止血、血栓形成、免疫反应、肿瘤转移等方面的新发现。
Crit Rev Clin Lab Sci. 2016 Dec;53(6):409-30. doi: 10.1080/10408363.2016.1200008. Epub 2016 Jul 22.
10
From Cell Interactions to Bedside Practice: Complete Blood Count-Derived Biomarkers with Diagnostic and Prognostic Potential in Venous Thromboembolism.从细胞相互作用到临床实践:全血细胞计数衍生的生物标志物在静脉血栓栓塞症中的诊断和预后潜力
J Clin Med. 2025 Jan 2;14(1):205. doi: 10.3390/jcm14010205.

本文引用的文献

1
Vascular Endothelium at the Molecular Level: From Fundamental Knowledge Toward Medical Implementation.分子水平的血管内皮:从基础知识到医学应用
Biomedicines. 2024 Dec 24;13(1):2. doi: 10.3390/biomedicines13010002.
2
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?静脉血栓与动脉血栓之间的联系:内皮功能障碍是否起作用?
Cells. 2025 Jan 20;14(2):144. doi: 10.3390/cells14020144.
3
The Basic Principles of Pathophysiology of Venous Thrombosis.静脉血栓形成病理生理学的基本原则。
Int J Mol Sci. 2024 Oct 24;25(21):11447. doi: 10.3390/ijms252111447.
4
Novel factors affecting fibrin clot formation and their clinical implications.影响纤维蛋白凝块形成的新因素及其临床意义。
Pol Arch Intern Med. 2024 Dec 19;134(12). doi: 10.20452/pamw.16884. Epub 2024 Nov 6.
5
Novel Insight into Inflammatory Pathways in Acute Pulmonary Embolism in Humans.急性肺栓塞中炎症途径的新见解。
Arch Immunol Ther Exp (Warsz). 2024 Oct 28;72(1). doi: 10.2478/aite-2024-0021. eCollection 2024 Jan 1.
6
Decoding Pulmonary Embolism: Pathophysiology, Diagnosis, and Treatment.解读肺栓塞:病理生理学、诊断与治疗
Biomedicines. 2024 Aug 23;12(9):1936. doi: 10.3390/biomedicines12091936.
7
Extracellular RNA and Endothelial TLR3 Link Inflammation and Venous Thromboembolism.细胞外RNA与内皮细胞Toll样受体3介导炎症反应与静脉血栓栓塞症的关联。
J Am Heart Assoc. 2024 Aug 6;13(15):e036335. doi: 10.1161/JAHA.124.036335. Epub 2024 Jul 19.
8
Is It Possible to Train the Endothelium?-A Narrative Literature Review.是否有可能训练内皮细胞?——一篇叙述性文献综述。
Life (Basel). 2024 May 10;14(5):616. doi: 10.3390/life14050616.
9
Expression level of neutrophil extracellular traps in peripheral blood of patients with chronic heart failure complicated with venous thrombosis and its clinical significance.慢性心力衰竭合并静脉血栓形成患者外周血中性粒细胞胞外陷阱表达水平及其临床意义。
J Cardiothorac Surg. 2024 Mar 15;19(1):129. doi: 10.1186/s13019-024-02506-3.
10
miRNA Regulation of Cell Phenotype and Parietal Remodeling in Atherosclerotic and Non-Atherosclerotic Aortic Aneurysms: Differences and Similarities.微小RNA在动脉粥样硬化性和非动脉粥样硬化性主动脉瘤中对细胞表型和壁重塑的调控:差异与相似性
Int J Mol Sci. 2024 Feb 24;25(5):2641. doi: 10.3390/ijms25052641.